Results 91 to 100 of about 2,669 (209)
To reduce the occupational hazard of chemotherapy in different kinds of cancer patients to clinical nurses. Through a lot of researches chemotherapy drug protection in recent years, the harmfulness of chemotherapy drugs on nurses are analyzed based on ...
Fan, Jie, Li, Ming-yue
core +2 more sources
Objective To explore the mediating effect of professional self-concept between the emotional resilience and perceived professional benefits in nursing students.
ZHAO Beibei (赵蓓蓓) +3 more
doaj +1 more source
苏颂,福建四大名医之一,泉州南安(今属厦门市同安区)人。北宋宰相,著名的政治家、科学家、医药学家。所著《本草图经》是本草学重要著作,苏颂以此书而不朽于杏林。然其在政治、外交、天文及机械制造方面的成就,当不在本草之下。
孙孝忠
core
摘要: (免费在线浏览)摘要:为适应专科护理的需要,提高操作技能和手术配合质量,手术室开展了多种形式的护理查房,激发了护士的工作积极性,提高了业务水平及工作质量。
阅读全文:0
doaj
Objective To explore the application effectiveness of the Internet-Plus hierarchical nursing training program based on the analysis-design-development-implementation-evaluation(ADDIE) teaching model in the training of Traditional Chinese Medicine nurses.
GUO Suyun (郭素云) +6 more
doaj +1 more source
中山大学附属第三医院推荐救治重型/危重型 COVID-19 方案 [PDF]
重型/危重型占所有新型冠状病毒肺炎(COVID-19)患者的比例为18%~20%,但病死率高达49.0%~61.5%,占所有COVID-19死亡的100%。高龄(> 60岁)和合并基础疾病是造成重型/危重型高病死率的主要原因。这主要与合并基础疾病的老年患者器官功能下降,耐受缺氧、炎症等损害的代偿能力降低,使其病程进展加速有关。因此,必须组建多学科团队,制定个体化方案,准确预判病情进展,及时干预,才能有效地降低病死率。我们具体的做法是施行了“多学科立体管理、个体化综合方案”的救治模式。方案遵守“三个原则”
core
Objective To understand the establishment and application experience of whole-course management nursing path for lymphoma patients by navigation nurses, and to provide reference for the construction of whole-course management for lymphoma patients ...
WANG Shijuan (王石娟) +6 more
doaj +1 more source
摘要: (免费在线浏览) 摘要:[目的]了解北京市“三甲”医院应用心电监护仪对急性冠状动脉综合征(ACS)病人进行ST段监测现况,分析不使用连续ST段监测的原因及相关因素。[方法]采取描述性研究的方法,对入选的心血管疾病监护病房(CCU)和急诊科护士进行问卷调查。[结果]护士在对ACS病人施行心电监护时最常选用的监护导联是Ⅱ导联(97.1%),心电监护的目的为监测心率(95.7%)、心律(97.1%)和心律失常(92.9%);仅有15名(21.4%)护士使用ST段监护功能 ...
吴瑛 +5 more
doaj
Objective To investigate the knowledge, attitude, and behavior of oncology nurses in Shanxi Province regarding cardiotoxicity associated with immune checkpoint inhibitors (ICIs).
FENG Yong (冯永) +4 more
doaj +1 more source

